StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
CRNX

Crinetics Pharmaceuticals, Inc.

CRNX Nasdaq Pharmaceutical Preparations EDGAR ↗
$83.76
+0.24 +0.29%

Key statistics

from XBRL data in SEC filings
Market cap
$8.88B
Revenue (TTM)
$42.2M
Net income (TTM)
-$502M
EPS (TTM)
$-5.05
P/E ratio
Dividend yield
Free cash flow
-$384M
Cash
$55.5M
Total assets
$1.32B
Gross margin
52-week range
$25.83 – $84.00

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-06-30 Aug 3, 2026 8-K Results of operations (earnings release) Aug 3, 2026 8-K Entered a material agreement; Director or officer change Jul 10, 2026 8-K Entered a material agreement; Other events Jul 6, 2026 8-K Shareholder vote results Jun 22, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Director or officer change Apr 10, 2026 8-K Director or officer change Mar 23, 2026 8-K Changed accountants Mar 3, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Director or officer change Jan 26, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2026 8-K Other events Jan 7, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 5, 2026 8-K Director or officer change Dec 17, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Regulation FD disclosure; Other events Sep 26, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Regulation FD disclosure Jun 30, 2025 8-K Regulation FD disclosure; Other events Jun 26, 2025 8-K Shareholder vote results Jun 12, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Director or officer change Apr 4, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Director or officer change; Regulation FD disclosure Feb 24, 2025 8-K Regulation FD disclosure Jan 14, 2025 8-K Regulation FD disclosure; Other events Jan 10, 2025 8-K Director or officer change; Regulation FD disclosure Dec 16, 2024 8-K Other events Dec 9, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Director or officer change Oct 16, 2024 8-K Other events Oct 9, 2024 8-K Other events Sep 26, 2024